What is Test(DW1401) used for?

Test(DW1401) is indicated for unknown.

Who makes Test(DW1401)?

Test(DW1401) is developed by Daewon Pharmaceutical Co., Ltd..

What are the side effects of Test(DW1401)?

Common side effects include unknown.

Last reviewed 2026-04-23 · How we verify

Test(DW1401)

Daewon Pharmaceutical Co., Ltd. · Phase 3 active Small molecule

Test(DW1401) is a small molecule drug that targets the molecular target.

Test(DW1401) is a small molecule drug that targets the molecular target. Used for unknown.

At a glance

Generic name	Test(DW1401)
Sponsor	Daewon Pharmaceutical Co., Ltd.
Drug class	small molecule
Target	unknown
Modality	Small molecule
Therapeutic area	unknown
Phase	Phase 3

Mechanism of action

The exact mechanism of action of Test(DW1401) is not well-documented, but it is believed to work by interacting with the molecular target, leading to a specific therapeutic effect.

Approved indications

unknown

Common side effects

unknown

Key clinical trials

To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Test(DW1401) CI brief — competitive landscape report
Test(DW1401) updates RSS · CI watch RSS
Daewon Pharmaceutical Co., Ltd. portfolio CI